Detalhe da pesquisa
1.
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients.
Am J Hematol
; 95(6): 623-629, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32239765
2.
Non-coding NOTCH1 mutations in chronic lymphocytic leukemia negatively impact prognosis.
Am J Hematol
; 97(3): E100-E102, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34989420
3.
Lymphomatous variant of hairy cell leukaemia: a distinctive presentation mimicking low-grade B-cell lymphoma.
Histopathology
; 67(5): 740-5, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25809821
4.
Clinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors.
Br J Haematol
; 182(5): 718-723, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28771675
5.
Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo(®) ) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non-Hodgkin lymphomas.
Br J Haematol
; 162(5): 631-8, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23802738
6.
Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL.
Blood Adv
; 4(6): 1038-1050, 2020 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32191807
7.
High incidence of IDH mutations in acute myeloid leukaemia with cuplike nuclei.
Br J Haematol
; 155(1): 125-8, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21480859